EXACT Sciences Corporation Stock News

Investors are optimistic about Exact Sciences (EXAS) on continued strength across the Screening and Precision Oncology businesses.

MADISON, Wis. , May 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate i

Demographic trends are powerful and experience little impact from economic cycles. As the Millennial generation enters middle age and surpasses the number of Baby Boomers, the demand for medical scree

Notable companies to have witnessed solid earnings acceleration as of now are ColgatePalmolive (CL), BigCommerce (BIGC) & Exact Sciences (EXAS).

Cathie Wood is a well-known though polarizing investor. As the founder and CEO of the investment management firm ARK Invest, she has an investment philosophy that focuses on innovative technologies a

Catherine Wood (Trades, Portfolio) disclosed her firm's first-quarter 2023 portfolio last week.

MADISON, Wis. , April 10, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its f

It's certainly not easy to find millionaire-maker stocks if you only have $50,000 or less to invest. In order to turn that amount of money into $1 million using a single stock, you'll need vision, a c

Population-based cancer screening is now closer than ever to becoming a reality. EXAS products have a leading market position in their respective markets, offering a solid foundation as the company ex

Oh, what A difference a year makes. Cathie Wood stocks in 2023 are doing so much better than the disaster in 2022.

Cathie Wood (Catherine Duddy Wood) is the founder and CEO of ARK Invest. Before founding ARK Invest, Wood was with AllianceBernstein as Chief Investment Officer of Global Thematic Strategies.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Exact Sciences (EXAS) closed the most recent trading day at $65.41, moving +1.93% from the previous trading session.

Sector ETF report for FBT

Stocks with potential are probably not everyone's cup of tea right now. With talks of an impending recession, everyone is looking for safer options.